Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-set and transmembrane domain-containing protein 2B (VSTM2B) is a predicted single-pass membrane protein encoded by the VSTM2B gene in humans. It is expressed in the brain and spinal cord mantle layer, but its exact molecular function, physiologic role, and mechanism of action remain poorly characterized. There is currently no evidence that VSTM2B functions as a receptor, enzyme, or classical therapeutic target. Some genomic and multi-omic studies list VSTM2B as part of gene panels in diverse biological contexts, but there are no established therapeutic drugs or disease biomarker applications as of the latest data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-set and transmembrane domain-containing protein 2B (VSTM2B).